Could a common supplement ease harmful behaviors in rare genetic disorder?
NCT ID NCT04381897
First seen Oct 31, 2025 · Last updated May 01, 2026 · Updated 28 times
Summary
This small pilot study tests whether N-acetylcysteine (NAC), a supplement that reduces oxidative stress, can lessen repetitive and self-injurious behaviors in people with Cornelia de Lange Syndrome (CdLS). Ten participants aged 13 to 35 will receive both NAC and a placebo at different times to see if NAC leads to meaningful improvements. The goal is to find a safer way to manage these challenging behaviors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNELIA DE LANGE SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.